Table 2 Comparison of demographic and biochemical characteristics between both groups.

From: Significance of LHCGR polymorphisms in polycystic ovary syndrome: an association study

Variables

Cases (N = 443)

Controls (N = 380)

p-value

Age

24 (21–27)

23 (21–26)

0.31

Age at Menarchea

13 (9–16)

13 (10–16)

0.03*

Obesity-related parameters

 BMI

23.3 (20.8–26.6)

21.6 (19.6–24.3)

 < 0.0001*

 WHR

0.89 (0.85–0.93)

0.82 (0.78–0.88)

 < 0.0001*

Lipid profile

 Cholesterol

168.9 (145–200)

154.2 (136–179.4)

 < 0.0001*

 Triglycerides

140 (93.5–193.8)

96.7 (55.5–134.7)

 < 0.0001*

 HDL

43.1 (36.8–50.2)

46 (39.4–56.3)

 < 0.0001*

 LDL-C

93.3 (67.2–126.5)

86.1 (67.7–111.6)

0.04*

 VLDL-C

27.9 (18.4–38.4)

19.3 (11.1–26.9)

 < 0.0001*

Hormonal profile

 LH

7.2 (4.5–10.2)

5.1 (2.9–6.5)

0.01*

 FSH

5.6(4.1–7.6)

5.8 (4.7–9)

0.69

 LH/FSH

1.06 (0.69–1.9)

0.83 (0.54–1.6)

0.06

 Testosterone levels

0.84 (0.67–1.11)

0.44 (0.36–0.72)

 < 0.0001*

  1. N: no of individuals; BMI: Body Mass Index; WHR: waist-hip-ratio; HDL: high-density lipoprotein; LDL: low density lipoprotein; VLDL: very low-density lipoprotein; LH: luteinising hormone; FSH: follicle stimulating hormone, Mann Whitney U test (Interquartile range).
  2. *p-value considered significant < 0.05.
  3. aMaximum and minimum percentile were used instead of interquartile.
Back to article page